Gemmer Asset Management’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98K Hold
35,000
0.01% 187
2026
Q1
$90.3K Hold
35,000
0.01% 172
2025
Q4
$109K Hold
35,000
0.01% 169
2025
Q3
$116K Hold
35,000
0.01% 169
2025
Q2
$116K Hold
35,000
0.01% 165
2025
Q1
$100K Hold
35,000
0.01% 155
2024
Q4
$81.2K Hold
35,000
0.01% 151
2024
Q3
$110K Hold
35,000
0.01% 148
2024
Q2
$77.3K Hold
35,000
0.01% 139
2024
Q1
$109K Hold
35,000
0.01% 131
2023
Q4
$136K Hold
35,000
0.02% 127
2023
Q3
$114K Hold
35,000
0.02% 124
2023
Q2
$112K Hold
35,000
0.02% 124
2023
Q1
$151K Hold
35,000
0.02% 122
2022
Q4
$149K Hold
35,000
0.02% 114
2022
Q3
$172K Hold
35,000
0.03% 114
2022
Q2
$107K Buy
+35,000
New +$110K 0.02% 108

Other funds holding ANIX

Gemmer Asset Management's ANIX Position: Q2 2026 in Review

Gemmer Asset Management held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 35,000 shares worth $98K. The position accounts for 0.01% of the portfolio, ranked #187.

Gemmer Asset Management first reported a position in ANIX in Q2 2022 and has held it in 17 quarters since. The position peaked at $172K in Q3 2022. 2 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Gemmer Asset Management held 35,000 shares of Anixa Biosciences worth $98K as of Q2 2026.
  • Gemmer Asset Management left its Anixa Biosciences share count unchanged in Q2 2026.
  • Anixa Biosciences made up 0.01% of Gemmer Asset Management's portfolio in Q2 2026, its #187 holding.
  • Gemmer Asset Management first reported a position in Anixa Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Gemmer Asset Management's Anixa Biosciences position peaked at $172K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Gemmer Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.